ArticlePloS one2024

Challenges and strategies in the soluble expression of CTA1-(S14P5)4-DD and CTA1-(S21P2)4-DD fusion proteins as candidates for COVID-19 intranasal vaccines.

Simson Tarigan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.